Tularik Inc.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
none
Next term end
When these terms end
Held patents by the year their term ends
2026 · 0 end2027 · 02028 · 02029 · 02030 · 0
Fee deadlines
No maintenance fee falls due on this company's record before Nov 21, 2027.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
No patent on this record is in force and held under this name now.
Also on record: 125 lapsed for an unpaid fee · 68 ended at full term · 1 surrendered on reissue. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
20 abandoned · 1 no status recorded
Showing 1 to 10 of 21, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.
| Application | Title | Filed | Status |
|---|---|---|---|
| 11/332,054 | CXCR3 antagonists | Jan 13, 2006 | Abandoned |
| 11/086,846 | Murine G Protein-Coupled Receptors | Mar 21, 2005 | Abandoned |
| 11/038,360 | Novel receptors | Jan 18, 2005 | Abandoned |
| 10/916,868 | Arylsulfonamidobenzylic compounds | Aug 11, 2004 | Abandoned |
| 10/867,183 | Gene amplification and overexpression in cancer | Jun 15, 2004 | Abandoned |
| 10/817,418 | Gene amplification and overexpression in cancer | Apr 5, 2004 | Abandoned |
| 10/749,530 | Dec 30, 2003 | No status recorded | |
| 10/456,932 | Combination therapeutic compositions and method of use | Jun 5, 2003 | Abandoned |
| 10/278,851 | Quinolinyl and Benzothiazolyl Modulators | Oct 21, 2002 | Abandoned |
| 10/273,575 | Polypeptides and nucleic acids associated with cancer | Oct 18, 2002 | Abandoned |
10 of 21 applications shown.
Pro members see all 21 published applications.